Not Yet Recruiting NA INTERVENTIONAL 1-arm
NCT06971848
Evaluation of Skin Tests in Biotherapy Allergies (ETCABIO)
Sponsor: University Hospital, Angers
Conditions
AL Amyloidosis Bronchial Carcinoma Cholangiocarcinoma Chronic Lymphocytic Leukemia Colorectal Adenocarcinoma Colorectal Cancer Esophageal Squamous Cell Carcinoma Follicular Lymphoma Heart Cancer Hepatocarcinoma Hodgkin's Lymphoma Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck Melanoma Neoplasms Myeloma Pleural Mesothelioma Small Cell Bronchial Carcinomas
Updated 2 times since 2025 Last updated: Jul 8, 2025 Started: Sep 30, 2025 Primary completion: Sep 30, 2027 Completion: Oct 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on AL Amyloidosis and Bronchial Carcinoma, this trial is actively recruiting participants. The trial is conducted by University Hospital, Angers and has accumulated 2 data snapshots since 2025. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
2 versions recorded-
Aug 2025 — Present [monthly]
Not Yet Recruiting NA
-
Jun 2025 — Aug 2025 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- University Hospital, Angers
Data source: University Hospital, Angers
For direct contact, visit the study record on ClinicalTrials.gov .